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Since their discovery in the late 1980s, chemokines 
have been hailed as major contributors in the recruitment 
and function of immune cells in health and in all types 
of inflammatory diseases. Expression and activity of 
chemokines and their receptors in cancer cells, stromal 
cells and tumor-associated myeloid cells have also 
increased the interest of targeting these molecules in 
cancer therapy. In addition, direct antimicrobial activity 
has been reported for many chemokines in vitro but in vivo 
validation remains scarce. Among the 45 or so members 
of this family, CXCL14, also named BRAK for its initial 
isolation from breast and kidney, has a particular status 
because it is an orphan chemokine for which no receptor 
has been unequivocally identified. Nevertheless, several 
reports indicate a chemotactic function for CXCL14 in 
homeostatic migration of dendritic cells and NK cells. The 
function of CXCL14 in cancer may depend on the tumor 
type as both suppressing and promoting activities have 
been reported. We initially established that CXCL14 had 
direct killing activity against skin Gram-positive bacteria 
and Candida albicans as well as on Gram-negative gut 
microbes such as E. coli [1]. 
In a recent study that we wish to highlight here, 
we have shown evidence that CXCL14 contributes to 
killing lung bacterial pathogens both in vivo and in vitro 
[2]. Structurally, CXCL14 has the conserved chemokine 
fold defined by a three-stranded β-sheet overlaid by a 
α-helix and maintained by two disulfide bridges. CXCL14 
homologs in all vertebrates differ from other chemokines 
by an abnormally short amino-terminus of only two amino 
acids located before the first disulfide bridge and normally 
required for triggering G protein-coupled receptors. 
We found that the antimicrobial activity of full-length 
CXCL14 against Gram-negative bacteria was reproduced 
by N-terminal peptides, particularly by the synthetically 
produced peptide consisting of the first 13 amino acids as 
well as by the 17 amino-acid N-terminal peptide generated 
by proteinase-3, a major neutrophil granule serine protease 
of neutrophils. Disulfide bonds were not required for this 
function. The core 14-54 amino acids lacking the N- and 
C-terminal tails of CXCL14 carried both antimicrobial 
and chemotactic activities. The C-terminal alpha-helix 
was dispensable for these functions. Importantly, we 
demonstrated that CXCL14-deficient (Cxcl14-/-) mice 
had a defective bacterial clearance in the lungs following 
intranasal inoculation with Streptococcus pneumoniae. 
In contrast, the high antimicrobial activity for CXCL14 
noted in vitro against Pseudomonas aeruginosa did not 
translate in an essential function in vivo as clearance 
was unaltered in Cxcl14-/- mice. This finding may be 
explained by the presence of additional antimicrobial 
peptides secreted at mucosal surfaces and/or by other 
cellular mechanisms with overlapping activity against 
this pathogen. In addition, it remains possible that the 
antimicrobial activity of CXCL14 in vivo depends in part 
on activity through a receptor. However, this possibility is 
unlikely because CXCL14 expression is poorly responsive 
to inflammatory reactions. In contrast to most chemokines 
recruiting inflammatory cells, CXCL14 expression is only 
moderately increased (in lungs [2]) or even downregulated 
(in skin [1]) following injury or infection.
The elephant in the room regarding the physiological 
function of CXCL14 remains the cause for susceptibility 
to premature death of Cxcl14-/- mice. According to the 
MGI database, at least six successful targeting attempts 
at knocking out the Cxcl14 gene have been made and 
three have been published. These three independent 
mouse lines have shown reproducible skewed genotype 
ratios at weaning age compared to expected Mendelian 
ratios: crossing heterozygous mice produced only 2-12% 
Cxcl14-/- mice instead of 25%; crossing heterozygous with 
homozygous mice only generated about 30% Cxcl14-/- mice 
instead of the expected 50% [2-4]. It is still incompletely 
clear if reduced numbers of Cxcl14-/- mice at weaning 
age is due to embryonic or perinatal mortality. CXCL14 
appears important for the accumulation of uterine NK cells 
during pregnancy measured at embryonic day E13.5 [5]. 
Unfortunately, genotype ratios were not reported in that 
study. Data mentioned (but not shown) suggest perinatal 
death rather than embryonic mortality [3]. One cause of 
perinatal death may be the reduced antimicrobial activity 
normally provided by CXCL14 against opportunistic 
microbes. Exposure to bacteria during or shortly after 
birth may lead to sepsis and rapid death. Another cause 
of perinatal mortality of Cxcl14-/- mice could be linked 
to reduced food intake and impaired adaptation abilities 
to a new environment as observed in adult Cxcl14-/- mice 
[4]. This may then lead to out-competition by fitter wild-
type or heterozygous littermates. However, the high 
mortality of newborn mice from homozygous mating 
also suggests intrinsic defects regardless of competition. 
Low birth weights in human infants and calorie-restricted 
pregnancies in macaques are associated with higher 
CXCL14 expression and methylation of CXCL14 in 
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umbilical cord blood and mesenchymal stem cells [6]. 
While CXCL14 expression and epigenetic changes may 
be biomarkers of an unfavorable environment during 
pregnancy, the consequences of epigenetic changes in 
CXCL14 are unknown. Finally, a third possibility for 
the abnormally high perinatal mortality of Cxcl14-/- mice 
is that the targeting of Cxcl14 affects the expression 
levels of a neighboring gene. Cxcl14 is located 45kb 
upstream of Neurog1 encoding Neurogenin 1, an 
important transcription factor regulating sensory neuron 
development. Incidentally, Neurog1-/- mice die perinatally 
with 100% penetrance [7]. In conclusion, CXCL14 
protein is an atypical, orphan chemokine that fulfills 
multiple functions in cellular recruitment, metabolism and 
microbial control. Further work is needed to determine 
which of these (or other) functions determine a favorable 
outcome in newborns.
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